Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Tolerability of Perampanel in Amyotrophic Lateral Sclerosis Patients

NCT03377309 is registered in ClinicalTrials.gov with American University of Beirut Medical Center as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03377309 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Tolerability of Perampanel in Amyotrophic Lateral Sclerosis Patients
Lead sponsor
American University of Beirut Medical Center
Phase
Phase 2
Overall status
Terminated
Start date
December 1, 2019
Completion date
July 1, 2021
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.